However,instead of attacking cancer cells, they are typically co-opted to support tumor growth, metastasis, and therapeutic ...
A group of researchers at the Medical University of South Carolina (MUSC) has recently developed a new stem cell therapy with a remarkable ability to reverse new-onset type 1 diabetes (T1D) in a mouse ...
Good morning, and welcome to the Passage Bio-Remix Therapeutics Merger Agreement Announcement Conference Call. I would like to remind you that this call is being recorded for replay. I will now turn ...
Round led by Lumira Ventures and Roche Venture Fund with new investment from SanofiCHICAGO, June 18, 2026 (GLOBE NEWSWIRE) -- COUR Pharma, a clinical-stage biotechnology company developing ...
Morgan Hayes pets an ostrich at an Alpha Roost Farms pen near Danville. The new ostrich-meat producer is filling a niche market opening up for people developing red-meat allergies from Alpha-Gal ...
The gut microbiome is not a mere spectator but an active player in colorectal cancer (CRC), driving tumor initiation and ...
Natera, Inc. , a global leader in cell-free DNA and precision medicine, and Aveta Biomics, Inc., a clinical-stage immuno-oncology company advancing first-in-class oral immunotherapies for solid tumors ...
Targeting PTMs in cancer. Schematic overview of major PTMs in tumor-targeted therapy, highlighting the principal modification classes and their associated targeting strategies. P, phosphorylation; Ac, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results